FR2187305B1 - - Google Patents

Info

Publication number
FR2187305B1
FR2187305B1 FR7321732A FR7321732A FR2187305B1 FR 2187305 B1 FR2187305 B1 FR 2187305B1 FR 7321732 A FR7321732 A FR 7321732A FR 7321732 A FR7321732 A FR 7321732A FR 2187305 B1 FR2187305 B1 FR 2187305B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7321732A
Other languages
French (fr)
Other versions
FR2187305A1 (OSRAM
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline & French Laboratories Ltd
Original Assignee
Smith Kline & French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US262903A external-priority patent/US3867380A/en
Priority claimed from US00289499A external-priority patent/US3855213A/en
Application filed by Smith Kline & French Laboratories Ltd filed Critical Smith Kline & French Laboratories Ltd
Publication of FR2187305A1 publication Critical patent/FR2187305A1/fr
Application granted granted Critical
Publication of FR2187305B1 publication Critical patent/FR2187305B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/36—Methylene radicals, substituted by sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
FR7321732A 1972-06-14 1973-06-14 Expired FR2187305B1 (OSRAM)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US262903A US3867380A (en) 1971-02-18 1972-06-14 3-Heterocyclic thiomethylcephalosporins
US00289499A US3855213A (en) 1971-02-18 1972-09-15 3-heterocyclic thiomethyl-cephalosporins
US35956773A 1973-05-11 1973-05-11

Publications (2)

Publication Number Publication Date
FR2187305A1 FR2187305A1 (OSRAM) 1974-01-18
FR2187305B1 true FR2187305B1 (OSRAM) 1976-12-03

Family

ID=27401552

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7321732A Expired FR2187305B1 (OSRAM) 1972-06-14 1973-06-14

Country Status (10)

Country Link
JP (1) JPS4949984A (OSRAM)
AU (1) AU474443B2 (OSRAM)
CA (1) CA999574A (OSRAM)
CH (1) CH585228A5 (OSRAM)
DE (1) DE2330307C2 (OSRAM)
ES (1) ES415874A1 (OSRAM)
FR (1) FR2187305B1 (OSRAM)
GB (1) GB1416503A (OSRAM)
IE (1) IE37793B1 (OSRAM)
NL (1) NL7308199A (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1035353A (en) * 1973-01-31 1978-07-25 Lee C. Cheney 3-thiolated-7-acylamidocephalosporanic acids
CA1074784A (en) * 1974-09-06 1980-04-01 Sumitomo Chemical Company N-ACYLAMINO-.alpha.-ARYLACETAMIDO CEPHALOSPORINS
IL49183A0 (en) * 1975-03-27 1976-05-31 Pfizer Novel cephalosporin derivatives,their preparation and pharmaceutical compositions containing them
JPS5346995A (en) * 1976-10-12 1978-04-27 Sangyo Kagaku Kenkyu Kyokai Antibacterial agents
US20110287112A1 (en) 2009-01-30 2011-11-24 Ono Pharmaceutical Co., Ltd. Prostate cancer progression inhibitor and progression inhibition method

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
AU474443B2 (en) 1976-07-22
ES415874A1 (es) 1976-02-01
DE2330307C2 (de) 1983-03-10
CA999574A (en) 1976-11-09
AU5695273A (en) 1974-12-19
DE2330307A1 (de) 1974-01-03
IE37793L (en) 1973-12-14
CH585228A5 (OSRAM) 1977-02-28
NL7308199A (OSRAM) 1973-12-18
GB1416503A (en) 1975-12-03
FR2187305A1 (OSRAM) 1974-01-18
JPS4949984A (OSRAM) 1974-05-15
IE37793B1 (en) 1977-10-12

Similar Documents

Publication Publication Date Title
JPS5230327B2 (OSRAM)
JPS4964038A (OSRAM)
FR2187305A1 (OSRAM)
JPS4957730U (OSRAM)
JPS4933463A (OSRAM)
JPS494373A (OSRAM)
SU445828A1 (OSRAM)
HU169439B (OSRAM)
JPS4990738A (OSRAM)
CS174337B1 (OSRAM)
CH561000A5 (OSRAM)
CH1427773A4 (OSRAM)
CH561656A5 (OSRAM)
CH561350A5 (OSRAM)
CH579673B5 (OSRAM)
CH576549B5 (OSRAM)
CH577110A5 (OSRAM)
CH568307A5 (OSRAM)
CH582150A5 (OSRAM)
CH575128A5 (OSRAM)
BG17866A1 (OSRAM)
CH568530A5 (OSRAM)
CH566534A5 (OSRAM)
CH576991A5 (OSRAM)
CH568085A5 (OSRAM)

Legal Events

Date Code Title Description
ST Notification of lapse